L-Balenine
L-Balenine is an orally active Pin1 inhibitor and intracellular pH buffer. L-Balenine enhances the phagocytic activity of macrophages, and promotes the expression of pro-inflammatory and anti-inflammatory cytokines during muscle degeneration. L-Balenine also upregulates the expression of myogenic marker genes associated with regeneration, thereby effectively driving skeletal muscle regeneration. L-Balenine can be widely used in studies related to skeletal muscle injury and its repair mechanisms.
For research use only. We do not sell to patients.
- CAS No.: 331-38-4
- Formula: C10H16N4O3
- Molecular Weight:240.26
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
L-Balenine (10 mM; 24 h) dose-dependently enhances the phagocytic activity of RAW264.7 macrophage cells[1].
L-Balenine (10 mM; 24 h) significantly enhances the phagocytic uptake of opsonized E. coli BioParticles by RAW264.7 macrophage cells, increasing bead uptake per cell to 2.38 times the control level[1].
L-balenine (2-4 mM; 60 seconds) potently and specifically inhibits the PPIase catalytic activity of purified recombinant Pin1 in a dose-dependent manner[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J (male, 6 weeks old at study start, CTX-induced skeletal muscle injury)[1]
-
Dosage:1% w/w balenine-enriched extract (containing 27.3% balenine)
-
Administration:p.o.; ad libitum; 2 weeks prior to Cardiotoxin (CTX) injection and up to 14 days post-injection
-
Result:Increased wet weight of CTX-injected TA muscle significantly compared to normal diet group at day 3 post-CTX injection.
Increased wet weight of CTX-injected TA muscle significantly at day 14 post-CTX injection compared to day 0, with no significant differences between days 0, 3, and 7.
Reduced average cell-to-cell membrane space in TA muscle to approximately 40% of that in normal diet group at day 7 post-CTX injection.
Upregulated relative mRNA expression of Pax7, MyoD1, myogenin, TNF-α, MCP-1, TGF-β1, and IL-10 significantly compared to normal diet group at day 3 post-CTX injection.
Upregulated relative mRNA expression of Myh3 significantly compared to normal diet group at day 7 post-CTX injection.
Chemical Information
-
CAS No. 331-38-4
-
Molecular Weight 240.26
-
Formula C10H16N4O3
-
SMILES
NCCC(N[C@H](C(O)=O)CC1=CN(C)C=N1)=O
-
Structure Classification
-
Initial Source
Freshwater turtles
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Phagocytosis Functional Assay
A phagocytosis functional assay measures the ability of phagocytic cells, such as neutrophils, macrophages, monocytes, or microglia/macrophages, to bind and internalize particulate targets including bacteria, yeast particles, beads, or myelin particles. Fluorescent flow-cytometry assays detect target uptake as fluorescence associated with gated phagocytes, while pH-sensitive dyes such as pHrodo increase signal in acidic phagosomal compartments and therefore preferentially report internalized particles rather than particles remaining outside the cell. Microscopy or high-content imaging can be used to confirm intracellular localization and, in some protocols, to follow uptake kinetics.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
LPS-Induced Endotoxemia/Systemic Inflammation
Lipopolysaccharide (LPS)-induced endotoxemia is a widely used in vivo model of acute systemic inflammation in which LPS, a Gram-negative bacterial endotoxin, activates innate immune signaling primarily through TLR4, leading to rapid and transient induction of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β in circulation and tissues. This cytokine surge is commonly used as a measurable readout of systemic inflammatory activation and immune dysregulation, and is typically assessed within hours after intraperitoneal LPS administration in mouse models of endotoxemia. The model captures key features of systemic inflammatory response syndrome, including cytokine release, immune cell activation, and downstream tissue responses, and has been used to evaluate anti-inflammatory interventions such as cytokine modulation, lipid mediators, and immune cell-targeting therapies.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)